<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05614986</url>
  </required_header>
  <id_info>
    <org_study_id>021-262</org_study_id>
    <nct_id>NCT05614986</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement</brief_title>
  <acronym>Neurcog TAVR</acronym>
  <official_title>Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement: Periprocedural Changes and Predictors of Improvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trail is for patients with mild cognitive impairment (MCI) who are receiving a&#xD;
      transcatheter aortic valve replacement (TAVR). We will assess changes in neurocognition&#xD;
      following TAVR with the 5 minute Montreal Cognitive Assessment (mini MoCA) when comparing pre&#xD;
      procedure with post procedure assessments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with mild cognitive impairment who are being treated with a TAVR can choose to take&#xD;
      part in this trial. This trial will prospectively enroll patients at 4 Baylor Scott &amp; White&#xD;
      facilities. 80 patients will be enrolled between all sites. The mini MoCA will be conducted&#xD;
      at the following time points: pre TAVR, 30 days post TAVR, and 6 months post TAVR. All other&#xD;
      data will be collected from patient charts and are considered standard part of their care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2022</start_date>
  <completion_date type="Anticipated">June 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neurocognition measured by Mini MoCA at 30 days post TAVR</measure>
    <time_frame>30 days post TAVR</time_frame>
    <description>Changes in neurocognition compared to baseline at 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurocognition measured by Mini MoCA at 6 months post TAVR</measure>
    <time_frame>6 months post TAVR</time_frame>
    <description>Changes in neurocognition compared to baseline at 6 months</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Patients with Mild Cognitive Impairment Undergoing TAVR</arm_group_label>
    <description>Patients will be treated with standard of care. In addition, patients will complete the mini MoCA at 3 time points</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5 minute Montreal Cognitive Assessment (mini MoCA)</intervention_name>
    <description>The mini MoCA will be completed by the patient before TAVR, and 30 days and 6 months after TAVR</description>
    <arm_group_label>Patients with Mild Cognitive Impairment Undergoing TAVR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing TAVR with mild cognitive impairment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 years or older&#xD;
&#xD;
          2. Undergoing a TAVR procedure&#xD;
&#xD;
          3. Possible MCI as determined by procedures already used in the TAVR clinics, including 1&#xD;
             of the 4:&#xD;
&#xD;
               1. MMSE &lt; 27&#xD;
&#xD;
               2. History of MCI, dementia, or stroke (CVA or TIA)&#xD;
&#xD;
               3. History of prescription treatment for MCI&#xD;
&#xD;
               4. Discretion of the investigator, physician, or clinic staff&#xD;
&#xD;
          4. Scores 25 or less on the mini MoCA exam&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. In another research study that doesn't allow dual enrolment, or dual enrolment has not&#xD;
        been granted.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Srinivasa Potluri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Scott and White The Heart Hospital Plano</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Hale</last_name>
    <phone>469-814-4845</phone>
    <email>sarah.hale@bswhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hale</last_name>
      <phone>469-814-4845</phone>
      <email>sarah.hale@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White All Saints at Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hale</last_name>
      <phone>469-814-4845</phone>
      <email>sarah.hale@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott and White The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hale</last_name>
      <phone>469-814-4845</phone>
      <email>sarah.hale@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Medical Center - Temple</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hale</last_name>
      <phone>469-814-4845</phone>
      <email>sarah.hale@bswhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mocatest.org/paper/</url>
    <description>MoCA Cognitive Assessment</description>
  </link>
  <results_reference>
    <citation>Auffret V, Campelo-Parada F, Regueiro A, Del Trigo M, Chiche O, Chamandi C, Allende R, Cordoba-Soriano JG, Paradis JM, De Larochelliere R, Doyle D, Dumont E, Mohammadi S, Cote M, Marrero A, Puri R, Rodes-Cabau J. Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Nov 15;68(20):2129-2141. doi: 10.1016/j.jacc.2016.08.046. Epub 2016 Sep 28.</citation>
    <PMID>27692728</PMID>
  </results_reference>
  <results_reference>
    <citation>Potluri S, Szerlip M, Al-Azizi K, Harrington K, Kodali S, Kapadia S, Lu M, Leon MB, Mack MJ. Neurocognitive Function Change in Low-Risk Patients Undergoing TAVR Versus SAVR: Insights From PARTNER-3. JACC Cardiovasc Interv. 2020 Nov 23;13(22):2713-2714. doi: 10.1016/j.jcin.2020.08.009. No abstract available.</citation>
    <PMID>33213758</PMID>
  </results_reference>
  <results_reference>
    <citation>Arevalo-Rodriguez I, Smailagic N, Roque I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.</citation>
    <PMID>25740785</PMID>
  </results_reference>
  <results_reference>
    <citation>O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008 Jul;65(7):963-7. doi: 10.1001/archneur.65.7.963.</citation>
    <PMID>18625866</PMID>
  </results_reference>
  <results_reference>
    <citation>Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x. Erratum In: J Am Geriatr Soc. 2019 Sep;67(9):1991.</citation>
    <PMID>15817019</PMID>
  </results_reference>
  <results_reference>
    <citation>Khan MM, Herrmann N, Gallagher D, Gandell D, Fremes SE, Wijeysundera HC, Radhakrishnan S, Sun YR, Lanctot KL. Cognitive Outcomes After Transcatheter Aortic Valve Implantation: A Metaanalysis. J Am Geriatr Soc. 2018 Feb;66(2):254-262. doi: 10.1111/jgs.15123. Epub 2017 Nov 21.</citation>
    <PMID>29159840</PMID>
  </results_reference>
  <results_reference>
    <citation>Liew TM. The Optimal Short Version of Montreal Cognitive Assessment in Diagnosing Mild Cognitive Impairment and Dementia. J Am Med Dir Assoc. 2019 Aug;20(8):1055.e1-1055.e8. doi: 10.1016/j.jamda.2019.02.004. Epub 2019 Mar 23.</citation>
    <PMID>30910550</PMID>
  </results_reference>
  <results_reference>
    <citation>Wong A, Nyenhuis D, Black SE, Law LS, Lo ES, Kwan PW, Au L, Chan AY, Wong LK, Nasreddine Z, Mok V. Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration. Stroke. 2015 Apr;46(4):1059-64. doi: 10.1161/STROKEAHA.114.007253. Epub 2015 Feb 19.</citation>
    <PMID>25700290</PMID>
  </results_reference>
  <results_reference>
    <citation>Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, Kabadi S, Ruparel K, Chen-Plotkin AS, Chahine LM, Dahodwala NA, Duda JE, Weintraub DA, Moberg PJ. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1303-1310. doi: 10.1136/jnnp-2015-312723. Epub 2016 Apr 12.</citation>
    <PMID>27071646</PMID>
  </results_reference>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAVR</keyword>
  <keyword>Transcatheter Aortic Valve Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

